After this breath, Chinese medicine enterprises have to plan the way of transformation

[pharmaceutical network market analysis] for Chinese patent medicine enterprises, it has been several waves since this year For example, on June 4, the Ministry of Finance organized accounting inspection on 77 pharmaceutical enterprises, including 33 traditional Chinese medicine manufacturers, accounting for more than chemical and biological pharmaceutical enterprises In July, when the national health and Health Commission released the list of key monitoring and rational use of drugs, it clearly put forward restrictions on prescription of Western medicine On August 20, when the National Health Insurance Bureau issued the 2019 version of the national health insurance catalogue, it also restricted the payment of medical insurance by prescribing traditional Chinese medicine in western medicine According to the industry, since this year, Chinese patent medicine enterprises in China have been facing a year of contraction and pressure, whether it is volume procurement, through audit, or medical insurance catalog adjustment, key drug catalog monitoring But what these policies have a great impact on the follow-up industry should be to prohibit western medicine from issuing Chinese patent medicine Banning western medicine from developing traditional Chinese medicine was once interpreted by the industry as one of the policy directions to crack down on Chinese patent medicine enterprises But recent policies in some places seem to give pharmaceutical companies a chance to breathe For example, on September 4, Shandong health and Health Commission issued a notice saying that doctors who have obtained the qualification of traditional Chinese medicine doctors and registered to practice, and who have received the course of traditional Chinese medicine in college education and post graduation education can issue prescriptions of traditional Chinese medicine General practitioners and rural doctors in primary medical institutions can prescribe commonly used Chinese patent medicines for common and frequently occurring diseases, or continue to use the long-term prescriptions of Chinese patent medicines issued by Chinese doctors At the same time, after not less than one year's systematic study of the professional knowledge of traditional Chinese medicine and passing the examination, according to the basic principles of syndrome differentiation and treatment of traditional Chinese medicine, the prescription of traditional Chinese medicine can be issued In addition, as early as in Shandong Province, on July 12, the Hebei administration of traditional Chinese medicine and the provincial health and Health Commission jointly issued a notice to make arrangements for the service of non traditional Chinese medicine doctors It was proposed that in five cases, western medicine can prescribe traditional Chinese medicine and provide traditional Chinese medicine services, and the practicing units of doctors have the key assessment rights In response, the industry said that these places will undoubtedly give new hope to the market of traditional Chinese medicine, especially traditional Chinese medicine, by liberalizing the restrictions on the prescription of traditional Chinese Medicine issued by western medicine However, some people in the industry also said that at present, although the implementation of the policy of completely cracking down on the indiscriminate use of traditional Chinese medicine in hospitals and completely banning the use of traditional Chinese medicine by western medicine has not reached the critical point, there is still a buffer period, for traditional Chinese medicine enterprises, once the hospital inventory is cleared, the period of the big limit of traditional Chinese medicine will not be far away It is urgent for Chinese medicine enterprises to seek transformation " For the transformation of traditional Chinese medicine enterprises, some enterprises expressed the transformation to the direction of biopharmaceutical research and development For example, a Chinese medicine enterprise said that at present, the company is transforming from a sales oriented company to a technology-based company; from Chinese patent medicine to biological medicine, chemical medicine, medical equipment, Internet medicine; and gradually from China's localization to globalization According to the analysis of the insiders, at present, the transformation of traditional Chinese medicine enterprises into bio medicine R & D is not a case The listed pharmaceutical enterprises represented by Jiuzhitang, Tianshili, and Changbu pharmaceutical have laid out the field of bio medicine, among which anti-tumor drugs and stem cell drugs are hot spots In addition, some analysts believe that according to the "healthy China" 2030 plan outline, traditional Chinese medicine needs to play a role in the "prevention and treatment of disease", taking a big health line, such as food, health food, daily chemicals, cosmetics and other categories may become the way for traditional Chinese Medicine enterprises to develop in the future The shuffling of traditional Chinese medicine industry is irreversible, and the transformation of traditional Chinese medicine enterprises has become a trend However, some analysts also pointed out that although the field of biological innovative drugs has become a hot spot, for traditional Chinese medicine enterprises, due to the large differences in the basis, it is particularly important for Chinese patent medicine enterprises to show scientific and data to prove the efficacy if they want to achieve leapfrog development For the enterprises of traditional Chinese medicine, first of all, traditional Chinese medicine pays attention to making good medicine Traditional Chinese medicine should grasp the standardized cultivation of raw materials, so that the quality standard of traditional Chinese medicine will be improved slowly "If the quality of traditional Chinese medicine is guaranteed, there will be confidence at the source." Secondly, we should use modern medical means to explain the safety and effectiveness of our traditional Chinese medicine, which is evidence-based medicine This requires big clinical and big data, with the modern new scientific clinical standard, to give a demonstration of evidence-based medicine to traditional Chinese medicine, which proves that traditional Chinese medicine is safe and effective.